inhibin A have been shown to rise across gestation particularly in the third trimester (Yohkaichiya et al., 1991; To compare maternal serum inhibin A concentrations in et al., 1995) reflecting a feto-placental origin in later pregnancy. early pregnancy with pregnancy outcomes and treatment However, there are conflicting reports regarding the source of protocols, serum samples were collected from 237 women inhibin A in the initial stages of pregnancy.
undergoing in-vitro fertilization (IVF) and embryo transfer
During the establishment of pregnancy, the corpus luteum cycles. Samples were collected on day 16 after oocyte plays a major role in maintenance of early gestational milieu retrieval for β human chorionic gonadotrophin (HCG) but its role gradually is replaced by that of the trophoblast and pregnancy testing and inhibin A measurement. The developing placenta. During early pregnancy, mRNAs for α, samples were divided into non-pregnant (n ϭ 128) and β A and β B subunits have been demonstrated in the follicles, pregnant (n ⍧ 109) groups, the pregnancies were followed corpus luteum (Roberts et al., 1993) and the trophoblast and outcomes determined. Inhibin A concentrations were (Meunier et al., 1988; Baird and Smith, 1993) . Immunohistosignificantly lower in non-pregnant women than in women chemical studies have demonstrated the presence of α, β A and with ongoing pregnancies (P < 0.001) and those resulting β B subunits in the corpus luteum and placental tissues (Petraglia in spontaneous abortions (P < 0.001). In ongoing pregnan Yamoto et al., 1991; Minami et al., 1992 ; cies, inhibin A concentrations were significantly lower in McCluggage et al., 1998) . Previous studies have reported a the absence of functioning ovaries (donor oocyte/embryo) major contribution of circulating inhibin from either the ovary (P < 0.01) and in natural cycles (frozen-thawed embryo (Yohkaichiya et al., 1991; Illingworth et al., 1996 ; Rombauts transfer) (P Ͻ 0.01) compared with concentrations after et al., 1996) McLachlan et al., 1987; were not significantly different between singleton and 1997) in spontaneous and in-vitro fertilization (IVF)-embryo multiple pregnancies in the ovarian stimulation protocol, transfer pregnancies. The apparent discrepancies appear to be the size of the early trophoblast does not appear to due, in part, to the different assays used, the stage of gestation influence the secretion of inhibin A. These data strongly and possibly the different hormonal treatment protocols used support the concept that the corpus luteum is a major in the IVF-embryo transfer cycles of women enrolled in these source of circulating inhibin A in early pregnancy.
studies. The early studies used a radioimmunoassay which, in Additionally, low concentrations of serum inhibin A may addition to measuring the dimeric inhibins, measured the be useful in predicting βHCG-positive preclinical 'biochemmonomeric free α subunit (Robertson et al., 1989) . Recently, ical' pregnancies.
a sensitive and specific two-site enzyme linked immunosorbent Key words: corpus luteum/inhibin A/in-vitro fertilization/outassay for inhibin A has been developed (Groome et al., 1994 ) comes/pregnancy which has enabled the study of this protein specifically. Different patterns of circulating inhibin A (Lockwood et al., 1997) and pro-αC (the pro region of the α subunit) (Illingworth Introduction et al., 1996) have been shown to be potential markers of pregnancy outcomes indicating the presence of non-viable Inhibins are heterodimeric proteins composed of an α and one of two β subunits, β A or β B , giving rise to two isoforms pregnancies. Several studies have attempted to relate parameters including inhibin A to ovarian reserve and subsequent inhibin A (αβ A) and inhibin B (αβ B ) and are defined by their ability to inhibit FSH secretion from the pituitary (de Kretser IVF pregnancy outcomes (Barnhart and Osheroff, 1998; Broekmans et al., 1998; Hall et al., 1999) . However, the and Robertson, 1989) . During the human menstrual cycle, the samples were divided into two groups: non-pregnant (n ϭ 128) dynamics of inhibin A secretion during establishment of and pregnant (n ϭ 109). All pregnancies were followed for a minimum pregnancy may be more useful in predicting IVF pregnancy of 12 weeks of gestation and were subsequently classified into four outcomes.
groups: (i) preclinical (Pcln, n ϭ 15); (ii) ectopic (Ect, n ϭ 2); (iii) Therefore, this study, in a large number of patients, was spontaneous abortion (Sp. Ab, n ϭ 12); and (iv) ongoing (n ϭ 80) undertaken to investigate whether serum inhibin A concentrapregnancies. A preclinical 'biochemical' pregnancy was diagnosed if tions on day 16 after oocyte retrieval in IVF-embryo transfer weekly βHCG concentrations declined and no fetal heart beat (FHB) cycles are correlated with subsequent pregnancy outcomes, was detected at 6-7 weeks of gestation by transvaginal ultrasonoand to determine whether different treatment protocols which graphy. Diagnosis of an ectopic pregnancy was made if FHB reflect different levels of corpus luteum function affect the was detected outside the uterine cavity. Spontaneous abortion was circulating concentrations of inhibin A in early pregnancy.
diagnosed if the previously positive intrauterine FHB became undetectable or pregnancy spontaneously terminated after 6-7 weeks of gestation. Ongoing pregnancy was diagnosed if the pregnancy
Materials and methods
continued beyond 12 weeks of gestation.
Subjects and samples
Further, all ongoing pregnancies were divided into four groups based The study was performed retrospectively on blood samples routinely on the hormonal treatment protocols as described above: (i) natural collected on day 16 after oocyte retrieval for the diagnosis of cycle (NAT, n ϭ 12); (ii) hormone replacement (HRT, n ϭ 4); (iii) pregnancy following IVF and embryo transfer. Permission for the use clomiphene citrate (clomiphene, n ϭ 4); and (iv) ovarian stimulation. of these samples for this study was given by the Ethics Committee
The ovarian stimulation group (n ϭ 60) was further subdivided into of the Epworth Hospital (Richmond, Victoria, Australia). After the groups with viable singleton (VS, n ϭ 39) or viable multiple fetus (VM, aliquots were used to measure β human chorionic gonadotrophin n ϭ 21) pregnancies. (βHCG) concentrations for pregnancy tests, the samples were stored at -20°C for further assays.
Assays βHCG was measured using a commercial assay kit (Vitros free Treatment protocols βHCG; Ortho-Clinical Diagnostics, Amersham, UK). The sensitivity A variety of hormonal treatment protocols was used in IVF-embryo of the assay was 0.04 mIU/ml. Inhibin A was measured by specific transfer cycles. methods previously described elsewhere (Groome et al., 1994) using WHO inhibin standard 91/624. The sensitivity of the assay Frozen-thawed cycles was 4 pg/ml. Intra-and inter-plate assay coefficients of variation (i) In women without functioning ovaries, embryo transfer was were 9.2 and 10.6% respectively. achieved using donated oocytes or frozen-thawed embryos. The endometrium was prepared using a hormonal replacement (HRT) Statistical analysis protocol whereby 4 mg daily orally of oestradiol valerate (Progynova ® ;
The data are presented as arithmetic mean Ϯ SEM and analysed Schering, Sussex, UK) was prescribed for 12-20 days. After embryo using Kruskal-Wallis non-parametric analysis with Dunn's post hoc transfer, additional luteal support was provided by 400-600 mg daily test. Inhibin A measurements lower than the detection limit of 4 pg/ progesterone vaginal suppositories at least until serum samples were ml were assumed to be 4 pg/ml for statistical purposes. Analyses collected. One woman, with some ovarian function but with repeated were carried out using the GraphPad Prism 2.01 software package IVF failures, underwent pituitary desensitization using a GnRH (GraphPad software Inc., San Diego, CA, USA). Ratios were calcuagonist, nafarelin (Synarel ® ; Searle, High Wycombe, UK) prior to lated with matched data for each patient and the mean of these preparation of the endometrium using the HRT protocol as above, is shown. and embryo transfer using a donated frozen-thawed embryo. (ii) In patients with functioning ovaries and regular menstrual cycles, replacement of their frozen embryos occurred using a natural cycle
Results
(NAT) in which the endometrium was prepared by endogenous Serum inhibin A and βHCG concentrations in women who oestradiol and progesterone.
were subsequently diagnosed with ongoing pregnancies were significantly higher than in non-pregnant women (P Ͻ 0.001)
IVF-embryo transfer cycles
( Figure 1) . Women with pregnancies later diagnosed as Two treatment protocols were used: (i) ovarian minimal stimulation preclinical had significantly lower inhibin A concentrations using clomiphene citrate; or (ii) ovarian stimulation, in which (P Ͻ 0.01) than those with ongoing pregnancies but no nafarelin was prescribed for pituitary desensitization and was significant difference in βHCG concentrations was noted.
followed by injection of human recombinant follicle stimulating hormone (rhFSH) (Gonal-F ® ; Ares-Serono, Geneva, Switzerland).
Inhibin A concentrations in women with pregnancies resulting When the dominant follicle or follicles were Ͼ17 mm diameter, in spontaneous abortions were not significantly different to the naferelin and rhFSH were discontinued and prior to oocyte retrieval, concentrations in ongoing pregnancies. However, in these 5000-10 000 IU s.c. of HCG (Profasi ® ; Serono Laboratories, Geneva, cases, a lower inhibin A to βHCG ratio (1.08 Ϯ 0.41) than Switzerland) was administered for oocyte maturation to subjects with that seen in ongoing pregnancies (1.61 Ϯ 0.26) was noted, but clomiphene or ovarian stimulation protocols. After embryo transfer, this difference was not significant. No significant differences in luteal support with 400-600 mg daily of progesterone vaginal inhibin A concentrations were found between the group of suppositories was prescribed for all women and continued at least women with ectopic and those with ongoing pregnancies. until the samples were collected.
However, a high inhibin A to βHCG ratio was noted in the small number of women with ectopic pregnancies (8.74 Ϯ Pregnancy outcomes 1.53), similar to that found in non-pregnant women (9.58
Pregnancy was diagnosed on day 16 after oocyte retrieval by the detection of 10 mIU/ml or higher of serum βHCG concentrations and Ϯ 0.67). are expressed in both the corpus luteum and trophoblast (Yamoto et al., 1991; Minami et al., 1992) . To investigate the source of circulating inhibin A in the early stages of gestation, Analysis of serum inhibin A and βHCG concentrations in women with ongoing pregnancies, according to the type of a variety of hormonal treatment protocols used in IVF-embryo transfer programmes and the number of fetuses in successful stimulation used in their IVF/embryo transfer cycle showed significant differences in circulating inhibin A concentrations pregnancies were examined. The different treatment protocols reflect different numbers of functional corpora lutea, whereas between some groups (Figure 2) . However, there was no significant change in the βHCG concentrations between treatthe number of viable fetuses reflects the mass of the trophoblast. ment groups. Inhibin A concentrations were significantly lower in cases where the women who received the HRT protocol Inhibin A concentrations in pregnant women reflected the number of corpora lutea arising from different IVF-embryo had no corpus luteum (P Ͻ 0.01) and during natural cycles (one corpus luteum) (P Ͻ 0.01) compared with those women transfer treatments. The inhibin A concentrations were significantly lower in cases where pregnancies occurred in women receiving the ovarian stimulation protocol (multiple corpora lutea). Inhibin A concentrations in women who received the without functioning ovaries (HRT protocol) reflecting the absence of a functional corpus luteum, and in women where ovarian stimulation protocol resulting in viable singleton and viable multiple pregnancies were not significantly different. In the endometrium was prepared by NAT protocol (single corpus luteum), compared with those women who received the ovarian contrast, βHCG concentrations were significantly higher in women with viable multiple pregnancies (P Ͻ 0.05) in comparstimulation protocol (multiple corpora lutea). Further, there was no significant difference in inhibin A concentrations ison with those with viable singleton pregnancies (Figure 2) . between viable singleton and multiple pregnancies. However, Discussion the increased trophoblast mass in multiple pregnancies was reflected in significantly higher βHCG concentrations comThis study demonstrates that serum inhibin A concentrations in early pregnancy (day 16 after oocyte retrieval and the day pared with singleton pregnancies. It is possible that the increased output of inhibin A from multiple corpora lutea may of the pregnancy test in IVF-embryo transfer programmes) be obscuring the differences in inhibin A secreted from the pregnancies likely to be ongoing whereas significantly lower concentrations were found in non-pregnant subjects and trophoblast at this stage of pregnancy. These findings support prior studies (Santoro et al., 1992; Yohkaichiya et al., 1993;  pregnancies later classified as preclinical 'biochemical' pregnancies. Although not significantly different, inhibin A concen- Rombauts et al., 1996) which showed that the corpus luteum was a source of circulating inhibins very early in pregnancy.
trations were lower in pregnancies resulting in spontaneous abortions compared to those in ongoing pregnancies. These It has been shown that inhibin production is increased in the corpus luteum stimulated by exogenous HCG (Illingworth results are similar to a prior study with smaller numbers of women (Lockwood et al., 1997) which showed that low et al., 1990). Illingworth et al. (1996) have demonstrated that the luteal phase corpus luteum is capable of increased and circulating inhibin A concentrations at the time of the first pregnancy test (4 weeks of gestation) were related to poor continued secretion of inhibin A but not inhibin B when stimulated by exogenous HCG in non-pregnant women, IVF pregnancy outcomes. In our study, however, inhibin A concentrations within the groups were quite variable and indicating the ovary is a potential source of inhibin A in early pregnancy. Rombauts et al. (1996) have shown higher inhibin showed overlap between groups. Therefore, these concentrations cannot be used at this point directly to predict pregnancy A concentrations in early pregnancies after IVF-embryo transfer than seen in spontaneous conceptions. The women in outcomes. A larger number of cases is needed to define the ranges of inhibin A concentrations at specific times after this study received HCG for luteal support which, despite comparable circulating concentrations of HCG in spontaneous embryo transfer and after differing ovarian stimulation regimes before diagnostic criteria are developed. Given the enormous and IVF pregnancies, may have influenced the inhibin A concentrations in the IVF pregnancies. However, our study variety of stimulation protocols and varying ovarian sensitivities, all of which may modify the mass of luteal tissue has shown a similar observation of higher inhibin concentrations when comparing pregnancies resulting from natural in the ovary after oocyte retrieval, the definition of such ranges may prove difficult. cycles compared to ovarian stimulation, with both groups receiving only progesterone for luteal support. To our knowInhibin A concentrations in a small number of cases consequently diagnosed as ectopic pregnancies were not significantly ledge, luteal support using progesterone has an effect directly by supporting the secretory endometrium but no significant different from those in cases later diagnosed as ongoing pregnancies, but a high inhibin A to βHCG ratio was noted, effect on function of the corpus luteum or trophoblast has been demonstrated. similar to that seen in non-pregnant women. However, a larger number of cases is needed to demonstrate this significance in Other studies have concluded that the placenta is the source of circulating concentrations on inhibin A in early pregnancy. ectopic pregnancies.
In conclusion, these findings demonstrate that, in addition Muttukrishna et al. (1997) showed a decrease in inhibin A concentrations after termination of pregnancy. They concluded to the trophoblast, the ovary is also a significant source of circulating inhibin A in early pregnancy. The study also shows that the removal of the feto-placental unit also removed the source of inhibin A. However, the removal of the fetus and that, whilst inhibin A concentrations at the time of pregnancy test, 16 days following oocyte retrieval in IVF-embryo transfer placenta may also have resulted in the removal of one or more sources of stimulation to the ovary. Both inhibin A and cycle, may not be useful for predicting poor pregnancy outcomes such as ectopic pregnancies or spontaneous abortions, progesterone fell to luteal values after the procedure, indicating the corpus luteum was still functional at this early stage of inhibin A may, however, be a useful marker in predicting βHCG positive 'biochemical' preclinical pregnancies. gestation. Recent studies have demonstrated similar inhibin A concentrations in pregnancies resulting from donor eggs and
